Search

New MSK research measures unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies; investigates oral bacteria’s link to gut microbiota depletion with implications for cancer patients; and shows how a universal opt-out approach could help more cancer patients quit smoking.

… Friday, May 10, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) measures unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies; investigates oral bacteria’s link to gut microbiota depletion with implications for cancer patients; and

In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs.

… Monday, September 16, 2013 Summary In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs. Derek Tan , a chemist and a member of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program , is searching

Memorial Sloan Kettering Cancer Center (MSK) announced that Cardinale Smith, MD, PhD, has joined the institution as the inaugural Chief Medical Officer (CMO).

… Thursday, May 29, 2025 Memorial Sloan Kettering Cancer Center (MSK) announced that  Cardinale Smith, MD, PhD , has joined the institution as the inaugural Chief Medical Officer (CMO). In this role, Dr. Smith oversees clinical quality, patient safety, regulatory compliance, and works with faculty and

Proton beam radiotherapy resulted in similar oncologic outcomes with less toxicity and improved quality of life than photon beam radiotherapy in patients with head and neck cancers, according to results of an MSK-led clinical trial presented today at the 2025 American Society for Radiation Oncology Annual Meeting.

… Monday, September 29, 2025 Proton beam radiotherapy resulted in similar oncologic outcomes with less toxicity and improved quality of life than photon beam radiotherapy (intensity modulated radiotherapy, IMRT) in patients with head and neck cancers, according to results of an MSK-led clinical trial presented

A new study from Memorial Sloan Kettering’s (MSK) Marcel van den Brink— in collaboration with Jarrod Dudakov, PhD, at the Fred Hutchinson Cancer Center — has identified a molecule that promotes thymus regeneration. The results could pave the way toward treatments that could one day help rejuvenate an aging or damaged thymus. For more information or to speak with an expert, contact Rebecca Williams at [email protected].

… Friday, January 12, 2018 Bottom line: A new study from Memorial Sloan Kettering’s (MSK) Marcel van den Brink— in collaboration with Jarrod Dudakov, PhD , at the Fred Hutchinson Cancer Center — has identified a molecule that promotes thymus regeneration. The results could pave the way toward treatments

Since its inception at MSK 10 years ago, the Immigrant Health and Cancer Disparities (IHCD) Service has made significant progress in addressing barriers to access to cancer treatment and other healthcare for underserved communities across New York City and beyond.

… Monday, April 26, 2021 Since its inception at Memorial Sloan Kettering Cancer Center 10 years ago, the Immigrant Health and Cancer Disparities (IHCD) Service has made significant progress in addressing barriers to access to cancer treatment and other healthcare for underserved communities across New

Dr. Diane Reidy-Lagunes discusses cannabis and cancer with MSK’s Director of Pediatric Integrated Medicine, Dr. Nirupa Raghunathan, and cancer survivor and winner of TV’s “Survivor: Africa”, Ethan Zohn.

… Wednesday, May 4, 2022 Cannabis is an ancient plant that has been used for rituals and medicine for 5,000 years. People with cancer have turned to cannabis — better known as weed or marijuana — to relieve effects of both the illness and the treatment. Because of its ever-changing legal status, studies

MSK has been named one of the top employers in the country, according to Forbes magazine’s 2022 list of America’s Best Large Employers. MSK placed at no. 4 out of 500 employers with more than 5,000 employees.

… Thursday, February 10, 2022 MSK has been named one of the top employers in the country, according to Forbes magazine’s 2022 list of America’s Best Large Employers. MSK placed at no. 4 out of 500 employers with more than 5,000 employees. MSK was featured on previous Forbes’ Best Employers lists but this

Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.

… Wednesday, October 9, 2013 Summary Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries. This image shows a cross section of a piece of tissue that was surgically

This photo essay showcases the critical role trainees play within MSK's research enterprise.

… Tuesday, September 3, 2024 The students and postdoctoral researchers who work and train in MSK’s laboratories drive discovery forward every day. Today they are vital partners. Tomorrow they will lead further progress at hospitals, research centers, and biomedical companies around the world.   Monica